Beshoy Benyamen, MD
NPI 1730679846ActiveIndividual· General Practice· Manning, SC
General Practice (MD) in Manning, South Carolina, licensed in SC, with an NPI issued in May 2018. Part D covered 119 prescriptions written in 2024, 82% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 9 companies reporting payments in 2025, $441.47 in all, mostly food and beverage. Lists McLeod Health Clarendon as a hospital affiliation.
Overview
| NPI | 1730679846 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | May 14, 2018 |
| Last updated in NPPES | May 15, 2026 |
| Certified by provider | May 15, 2026 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| General Practice Primary | 208D00000X | 92095 | SC |
| Family Medicine | 207Q00000X | LL92095 | SC |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 4, 2026 | No match | — |
| New York OMIG · Nov 4, 2026 | No match | — |
| Ohio Medicaid · Nov 4, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 4, 2026 | No match | — |
| Washington HCA · Nov 4, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - General Surgery (NC); Practitioner - General Surgery (SC) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 119 · 175 30-day fills |
|---|---|
| Patients | 40 |
| Total drug cost | $9,928 |
| Generic share | 82% of claims |
Education and affiliations
| Graduation year | 2010 |
|---|---|
| Medicare specialty | General Surgery |
Hospital affiliation
- McLeod Health ClarendonManning, SC
Industry payments (Open Payments)
- 2025$441.47 · 24 payments from 9 companies
- 2024$93.71 · 5 payments from 4 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $162.79 | 12 |
| Novo Nordisk Inc | $70.09 | 1 |
| Novartis Pharmaceuticals Corporation | $67.92 | 4 |
| Abbvie Inc. | $44.62 | 2 |
| Boston Scientific Corporation | $26.62 | 1 |
What the 2025 payments were for
- Food and Beverage$441.47 · 24 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records